Richard Daniell - Net Worth and Insider Trading

Richard Daniell Net Worth

The estimated net worth of Richard Daniell is at least $2 Million dollars as of 2025-07-25. Richard Daniell is the Exec. VP, European Commercial of Teva Pharmaceutical Industries Ltd and owns about 96,769 shares of Teva Pharmaceutical Industries Ltd (TEVA) stock worth over $2 Million. Details can be seen in Richard Daniell's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Richard Daniell has not made any transactions after 2025-03-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Richard Daniell

To

Richard Daniell Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Richard Daniell owns 1 companies in total, including Teva Pharmaceutical Industries Ltd (TEVA) .

Click here to see the complete history of Richard Daniell’s form 4 insider trades.

Insider Ownership Summary of Richard Daniell

Ticker Company Transaction Date Type of Owner
TEVA Teva Pharmaceutical Industries Ltd 2025-03-05 Exec. VP & European Commercial

Richard Daniell Latest Holdings Summary

Richard Daniell currently owns a total of 1 stock. Richard Daniell owns 96,769 shares of Teva Pharmaceutical Industries Ltd (TEVA) as of March 5, 2025, with a value of $2 Million.

Latest Holdings of Richard Daniell

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TEVA Teva Pharmaceutical Industries Ltd 2025-03-05 96,769 16.33 1,580,238

Holding Weightings of Richard Daniell


Richard Daniell Form 4 Trading Tracker

According to the SEC Form 4 filings, Richard Daniell has made a total of 14 transactions in Teva Pharmaceutical Industries Ltd (TEVA) over the past 5 years, including 0 buys and 14 sells. The most-recent trade in Teva Pharmaceutical Industries Ltd is the sale of 140,372 shares on March 5, 2025, which brought Richard Daniell around $2 Million.

Insider Trading History of Richard Daniell

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Richard Daniell Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Richard Daniell Ownership Network

Ownership Network List of Richard Daniell

No Data

Ownership Network Relation of Richard Daniell

Insider Network Chart


Richard Daniell Owned Company Details

What does Teva Pharmaceutical Industries Ltd do?

Who are the key executives at Teva Pharmaceutical Industries Ltd?

Richard Daniell is the Exec. VP & European Commercial of Teva Pharmaceutical Industries Ltd. Other key executives at Teva Pharmaceutical Industries Ltd include EVP & Chief Financial Officer Eliyahu Sharon Kalif , EVP & International Markets Mark Sabag , and EVP & Business Development Evan Lippman .

Teva Pharmaceutical Industries Ltd (TEVA) Insider Trades Summary

Over the past 18 months, Richard Daniell made 6 insider transaction in Teva Pharmaceutical Industries Ltd (TEVA) with a net sale of 475,266. Other recent insider transactions involving Teva Pharmaceutical Industries Ltd (TEVA) include a net sale of 100,893 shares made by Eric A Hughes , a net sale of 615,541 shares made by Mark Sabag , and a net sale of 189,075 shares made by Eliyahu Sharon Kalif .

In summary, during the past 3 months, insiders sold 399,896 shares of Teva Pharmaceutical Industries Ltd (TEVA) in total and bought 0 shares, with a net sale of 399,896 shares. During the past 18 months, 2,585,734 shares of Teva Pharmaceutical Industries Ltd (TEVA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 2,585,734 shares.

Teva Pharmaceutical Industries Ltd (TEVA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Teva Pharmaceutical Industries Ltd Insider Transactions

No Available Data

Richard Daniell Mailing Address

Above is the net worth, insider trading, and ownership report for Richard Daniell. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Richard Daniell's mailing address is: Petach Tikva L3 4951033.